| |
| |
|
| Insider
Information: |
Megna Michael R |
| Relationship: |
|
| City: |
Rockland |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
21,328 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$406,298 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,328 |
|
|
| Total
Value |
$406,298 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
21,328 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2020-06-30 |
4 |
A |
$9.51 |
$6,096 |
D/D |
641 |
1,778 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2020-12-31 |
4 |
A |
$15.02 |
$6,083 |
D/D |
405 |
2,183 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2021-07-15 |
4 |
A |
$11.49 |
$6,756 |
D/D |
588 |
2,771 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2022-01-15 |
4 |
A |
$9.63 |
$6,288 |
D/D |
653 |
3,424 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
775 |
4,199 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Accounting Officer |
• – – |
2022-03-16 |
4 |
D |
$10.13 |
$2,725 |
D/D |
(269) |
3,930 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-03-21 |
4 |
D |
$10.98 |
$12,298 |
D/D |
(1,120) |
6,041 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,231 |
7,161 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-07-15 |
4 |
A |
$9.56 |
$6,721 |
D/D |
703 |
6,744 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
775 |
7,519 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-09-02 |
4 |
D |
$11.44 |
$2,608 |
D/D |
(228) |
7,291 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-10-04 |
4 |
D |
$14.23 |
$740 |
D/D |
(52) |
7,414 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
175 |
7,466 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-01-15 |
4 |
A |
$9.56 |
$6,730 |
D/D |
704 |
8,118 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
774 |
8,892 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$2,533 |
D/D |
(221) |
8,671 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,163 |
10,834 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$7,061 |
D/D |
(635) |
10,199 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$12,370 |
D/D |
(1,155) |
12,977 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,933 |
14,132 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-07-15 |
4 |
A |
$12.35 |
$7,175 |
D/D |
581 |
13,558 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,933 |
17,491 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$20,513 |
D/D |
(1,155) |
16,336 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$4,049 |
D/D |
(228) |
16,882 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
774 |
17,110 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
